Cypriot presidency EU’s Health Package is Europe’s answer to Trump’s drug pricing policy, says Várhelyi Várhelyi estimated reforms could lower business costs by 20-25 percent - potentially offsetting the impact of US tariffs and "MFN" pricing.
Inside EU Health Inside EU Health: Europe invests in 10-year preparedness research plan; Biotech Act I rapporteurs; EU and Canada health agencies joint plan; HTA report Europe invests €240 million ten-year pandemic preparedness research; Biotech Act I rapporteurs confirmed; EU and Canada health agencies deepen ties; HTA annual report on first year of implementation
Inside EU Health Inside EU Health: WHO defends itself from US slurs; pilot targets 70-day clinical trial approvals; less than 1% of research spent on key women’s health issues WHO defends itself against US accusations; FAST-EU pilot targets 70-day clinical trial approvals; less than 1% of research funding goes to key women’s health conditions
Biotech Act Europe pushes to regain ground on competitors with new Biotech Act With the publication of the Biotech Act, the EU sets out how it intends to boost the sector’s competitive position in the face of China’s rapid rise
Inside EU Health Inside EU Health: Biotech Act(s); WHO preparedness; and study on drug spending dynamics Biotech Act(s); WHO preparedness; EMA consults on primates in research; and IQVIA study on drug spending dynamics
Biotech Act Commission takes a two step approach to Biotech Act Commission presses ahead with health-focused Biotech Act I' in 2025, with a broader framework to follow in 2026
Competitiveness Várhelyi sets out his sweeping plans to reshape Europe’s competitiveness in health EU Health Commissioner Várhelyi has many ambitious plans and a tight schedule
